Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-24 · accession 0001127602-25-006830 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-26 | 2025-02-24 | TMO | Lowery Frederick M. | EVP | M - OptEx | $210.68 | +18.3K | 35.3K | +108% | +$3.86M |
| D | 2025-02-26 | 2025-02-24 | TMO | Lowery Frederick M. | EVP | S - Sale+OE | $531.81 | -18.3K | 17.0K | -52% | -$9.73M |
| D | 2025-02-26 | 2025-02-24 | TMO | Lowery Frederick M. | EVP | M - OptEx | $0.00 | -18.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | M | A | 18,300 | $210.68 | 35,254.01 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-24 | S | D | 18,300 | $531.81 | 16,954.01 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-02-24 | M | D | 18,300 | $0.00 | 0 | D | $210.68 · — to 2025-02-27 | 18,300 Common Stock | (F3) The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022. |